Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Lynde

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|July 25, 2000
Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patientsA K Gupta, H C Jain, C W Lynde, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2013
Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trialR Bissonnette, S Nigen, R G Langley, et al.
Pediatric Dermatology|December 12, 2001
Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazoleA K Gupta, P Adam, N Dlova, et al.
European Journal of Dermatology : EJD|December 10, 1999
Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agentsA K Gupta, N Konnikov, C W Lynde, et al.
Contact Dermatitis|July 1, 1982
Patch testing with mercaptobenzothiazole and mercapto-mixesC W Lynde, J C Mitchell, R M Adams, et al.
Lancet (London, England)|April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III studyK Papp, R Bissonnette, L Rosoph, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2016
Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis CouncilJ J Wu, C W Lynde, C E Kleyn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2016
The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' officesA K Gupta, G Gupta, H C Jain, et al.
The British Journal of Dermatology|August 1, 1997
Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre studyA K Gupta, M E Alexis, N Raboobee, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 2, 2014
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)K A Papp, K Barber, R Bissonnette, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|July 25, 2000
Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patientsA K Gupta, H C Jain, C W Lynde, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2013
Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trialR Bissonnette, S Nigen, R G Langley, et al.
Pediatric Dermatology|December 12, 2001
Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazoleA K Gupta, P Adam, N Dlova, et al.
European Journal of Dermatology : EJD|December 10, 1999
Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agentsA K Gupta, N Konnikov, C W Lynde, et al.
Contact Dermatitis|July 1, 1982
Patch testing with mercaptobenzothiazole and mercapto-mixesC W Lynde, J C Mitchell, R M Adams, et al.
Lancet (London, England)|April 22, 2008
Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III studyK Papp, R Bissonnette, L Rosoph, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2016
Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis CouncilJ J Wu, C W Lynde, C E Kleyn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2016
The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30 000 patients visiting physicians' officesA K Gupta, G Gupta, H C Jain, et al.
The British Journal of Dermatology|August 1, 1997
Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre studyA K Gupta, M E Alexis, N Raboobee, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 2, 2014
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)K A Papp, K Barber, R Bissonnette, et al.
Pageof 6